Atlas Trials

A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

Clinical trial NCT00246987 · COMPLETED

Trial details

NCT number
NCT00246987
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes, Type 2
Start date
2003-06-01
Enrollment
341

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.